Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT00724386
First received: July 25, 2008
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)